Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10769 - 10776 of 12026 results
DoD Requires Safeguarding Technical Data
December 11, 2013| Blog| Viewpoint
Data Security Advisory for Federal Contractors: Safeguarding Unclassified Controlled Technical Information
December 11, 2013| Advisory| Viewpoint
Beware of What You Wish for, You Might Get It
December 10, 2013| Blog| Viewpoint
MIT Clean Energy Prize 2014 Kick-Off Event at Mintz Boston Offices on Friday, December 13
December 10, 2013| Blog| Viewpoint
On the Second Day of Privacy, California Gave to Me......
December 10, 2013| Blog| Viewpoint
Collection of Email Addresses in Credit Card Transactions May Be Prohibited by California Law
December 10, 2013| Alert| Viewpoint
Willful Infringement of Copyright in Haitian Earthquake Photographs Cost AFP and Getty $1.2 Million
December 9, 2013| Blog| Viewpoint
On the First Day of Privacy, The OCR Gave to Me .....
December 9, 2013| Blog| Viewpoint
News & Press Releases
San Francisco Business Times featured Mintz’s new office lease in San Francisco at 525 Market St. The firm will be increasing its footprint in downtown by 50% to 29,000 square feet on a whole single floor with the new space.
Mintz advised the underwriters in connection with a $230 million public offering by Cogent Biosciences, Inc. of 25,555,556 shares of common stock, which includes 3,333,333 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock, offered at a public offering price of $9.00 per share. The aggregate gross proceeds to Cogent from this offering were approximately $230 million, including proceeds from the exercise in full by the underwriters of the option to purchase additional shares, before deducting underwriting discounts and commissions and other offering expenses.
Mintz advised the underwriters in connection with a $200 million public offering by Soleno Therapeutics, Inc. of 2,352,941 shares of its common stock at a price to the public of $85.00 per share. The gross proceeds to Soleno from the offering were approximately $200 million before deducting underwriting discounts and commissions and other offering expenses. In addition, Soleno granted the underwriters a 30-day option to purchase up to an additional 352,941 shares of its common stock at the public offering price.
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|